ABSTRACT
Porcine factor VIII (FVIII; Hyate:C; Speywood Biopharm Ltd, UK) has been used since 1980 for the treatment both of patients with acquired haemophilia and those with congenital haemophilia and inhibitory antibodies. Each batch is extensively screened using cell-culture techniques to confirm the absence of viruses. The production process does not incorporate specific virucidal treatment steps, such as heat treatment or the addition of a solvent/detergent mixture. Low levels of porcine parvovirus were detected in some batches of the product in late 1996 and supply was suspended. In this retrospective study, sera from 81 recipients of porcine FVIII and 125 other volunteers were screened for evidence of antibodies against a range of porcine viruses: porcine parvovirus (PPV), encephalomyocarditis virus (EMCV), and porcine respiratory and reproductive syndrome virus (PRRSV). The 125 volunteer controls included subjects from six categories: healthy control subjects, pig abattoir personnel, personnel involved in the manufacture of porcine FVIII, recipients of porcine heparin, recipients of porcine insulin, and haemophiliacs treated only with human FVIII. No antibodies to PPV or PRRSV were detected in any subject. Four patients and two volunteers were found to have antibodies to EMCV, but this incidence is similar to that observed in the general population. In conclusion, there was no evidence of transmission of PPR or other marker porcine virus associated with the use of porcine FVIII concentrate (Hyate: C).
Subject(s)
Drug Contamination , Factor VIII/therapeutic use , Hemophilia A/drug therapy , Parvoviridae/isolation & purification , Animals , Antibodies, Viral/blood , Hemophilia A/virology , Humans , Male , Parvoviridae/immunology , Porcine respiratory and reproductive syndrome virus/immunology , Porcine respiratory and reproductive syndrome virus/isolation & purification , Retrospective Studies , SwineABSTRACT
The kinetics of binding of oestradiol and the steroidal pure antioestrogen ICI 164,384 to the molybdate-stabilized oestrogen receptor, partially purified from pig and human uterine tissue, were determined. ICI 164,384 bound directly to the oestrogen receptor protein and the kinetic parameters of this interaction were, in general, similar to those for the binding of oestradiol, regardless of the source of the receptor protein. However, the rate of association of oestradiol, regardless of the source of the receptor protein. However, the rate of association of the antagonist with the receptor protein was slower when compared to that of oestradiol. Furthermore, the concentration of binding sites for the two ligands was of the same order. The binding of oestradiol resulted in a steroid-receptor complex which could be transformed in vitro, to a form with increased affinity for DNA-cellulose. However, the complex formed between ICI 164,384 and the receptor protein did not show increased affinity for DNA-cellulose when exposed to conditions that transformed agonist-receptor complexes. Therefore, the binding of ICI 164,384 to the oestrogen receptor protein results in a suppression of the transformation process. A similar suppression in vivo may account for the pure antagonist properties of ICI 164,384.
Subject(s)
Estradiol/analogs & derivatives , Estradiol/metabolism , Estrogen Antagonists/metabolism , Receptors, Estrogen/metabolism , Animals , Estradiol/pharmacology , Female , Molybdenum/pharmacology , Polyunsaturated Alkamides , Swine , TemperatureABSTRACT
The use of partially purified preparations of the human uterine oestrogen receptor has enabled, for the first time, a study of the binding of the steroidal, pure antioestrogen ICI 164,384 [N-n-butyl-11-(3,17 beta-dihydroxy-oestra-1,3,5(10)-trien-7 alpha-yl)N-methyl-undecamide] to the oestrogen receptor. Scatchard analyses of the binding of [3H]oestradiol and [3H]ICI 164,384 to the receptor show that the equilibrium dissociation constants for the interactions of these ligands with the receptor at 0 degrees C are 0.44 and 0.69 nM respectively. The concentration of receptor binding sites for the agonist was 1986 fmol/mg protein whilst that for the antagonist was 1400 fmol/mg protein. The affinity of the antioestrogen-receptor complex for DNA-cellulose does not increase following exposure to conditions that transform the oestrogen-receptor complex.
Subject(s)
Estradiol/analogs & derivatives , Estrogen Antagonists/metabolism , Receptors, Estrogen/metabolism , Uterus/metabolism , Estradiol/metabolism , Female , Humans , Kinetics , Polyunsaturated AlkamidesABSTRACT
Glucocorticoid-receptor complexes in rat thymus cytosol were characterized by gel-filtration chromatography on Agarose A-1.5 m and Sephacryl S-300. Two forms of non-transformed complex were identified at low ionic strength in the presence of molybdate, with Stokes radii of approx 8 nm and 6 nm. The 8 nm molybdate-stabilized form could be converted to the 6 nm form by chromatography on Sephacryl S-300 or Lipidex 1000 or by incubation with dextran-charcoal or phospholipase C, but not by chromatography on Sephadex G-25; none of the treatments promoted receptor transformation. It is suggested that the change in Stokes radius from 8 to 6 nm results from the removal of a lipid factor responsible for maintaining the complex in the 8 nm form.
Subject(s)
Glucocorticoids/analysis , Molybdenum/pharmacology , Receptors, Glucocorticoid/analysis , Animals , Chromatography, Gel , Male , Rats , Rats, Inbred Strains , Thymus Gland/analysis , Type C Phospholipases/pharmacologyABSTRACT
The physicochemical properties of complexes formed between the glucocorticoid antagonist, RU38486, and the glucocorticoid receptor in rat thymus cytosol were investigated and compared with those of complexes formed with the potent agonist, triamcinolone acetonide. The equilibrium dissociation constant for the interaction of [3H]RU38486 with the molybdate-stabilized glucocorticoid receptor was lower than that for [1,2,4-3H]triamcinolone acetonide at 0 degree C but higher at 25 degrees C, suggesting that hydrophobic interactions play a major role in the binding of RU38486. Differences in equilibrium constants were reflected in corresponding differences in dissociation rate constants; association rate constants for the two steroids were similar. The rate of dissociation of [3H]RU38486 from the glucocorticoid receptor was higher in the absence of molybdate than in its presence both at 0 degree C and at 25 degrees C, suggesting that molybdate modifies the physical state of the antagonist-receptor complex, but other physical properties were similar both in the presence and in the absence of molybdate. The rate of inactivation of the unoccupied glucocorticoid receptor at 25 degrees C in the absence of molybdate was lower in phosphate buffer than in Tris-HCl buffer but the rate of dissociation of [3H]RU38486 was the same in both buffers. The binding of RU38486 afforded little, if any, protection against inactivation in either buffer; [3H]RU38486 dissociated irreversibly from the inactivated receptor at the same rate as from the non-inactivated complex but molybdate had no effect on the dissociation kinetics of the inactivated complex. It is concluded that RU38486 interacts with the ground state of the glucocorticoid receptor in a manner which neither promotes receptor transformation nor prevents receptor inactivation.
Subject(s)
Estrenes/metabolism , Molybdenum/pharmacology , Receptors, Glucocorticoid/metabolism , Animals , Cytosol/metabolism , Ethylmaleimide/pharmacology , Glucocorticoids/antagonists & inhibitors , In Vitro Techniques , Male , Mifepristone , Models, Chemical , Rats , Receptors, Glucocorticoid/drug effects , Temperature , Thymus Gland/metabolism , Trifluoperazine/pharmacologyABSTRACT
Glucocorticoid-receptor complexes in rat thymus cytosol were characterized by gel-filtration and ion-exchange chromatography and by other procedures. Two forms of non-transformed complex were identified at low ionic strength in the presence of molybdate, with Stokes radii of approx. 8 and 6 nm. The 8 nm molybdate-stabilized form could be converted to the 6 nm form by chromatography on Sephacryl S-300 or Lipidex 1000 or by incubation with charcoal or phospholipase C, but not by chromatography on Sephadex G-25. The dissociation rate of the complex was reduced by treatment with charcoal or Lipidex 1000, but none of the treatments caused transformation to a DNA-binding form. Transformation of the complex, by exposure to elevated temperature or ionic strength in the absence of molybdate, resulted in the appearance of a different 6 nm form, distinguished by an increased affinity for DNA-cellulose and a reduced affinity for DEAE-cellulose. These results suggest that receptor transformation is preceded by structural changes associated with the loss of a lipid factor from the complex. Non-polar steroid antagonists, and lipophilic compounds such as phenothiazines, were found to bind to secondary, hydrophobic sites on the receptor and to exert allosteric effects on the primary steroid-binding site; these and other observations emphasize the importance of hydrophobic interactions as determinants of the structure and properties of glucocorticoid receptors.
Subject(s)
Receptors, Glucocorticoid/analysis , Allosteric Regulation , Animals , Binding Sites , Charcoal/pharmacology , Chromatography, Gel , Dexamethasone/metabolism , Dextrans/pharmacology , Kinetics , Male , Molybdenum/pharmacology , Rats , Rats, Inbred Strains , Receptors, Glucocorticoid/metabolism , TritiumABSTRACT
The glucocorticoid hormone-receptor complex has been shown to exist in several forms. The transformation status of various forms of the complex isolated from rat thymus cytosol in the presence of molybdate was determined. The non-transformed receptor had a higher affinity for DEAE-cellulose than the transformed receptor. The rate at which the non-transformed complex was transformed to a smaller form with a low affinity for DEAE-cellulose by exposure to salt was greater in the absence of molybdate than in its presence. We conclude that salt-induced transformation of the complex is retarded but not prevented by molybdate and is associated with subunit dissociation.
Subject(s)
Molybdenum/pharmacology , Receptors, Glucocorticoid/analysis , Receptors, Steroid/analysis , Animals , Chromatography, DEAE-Cellulose , DNA/metabolism , Osmolar Concentration , Potassium Chloride/pharmacology , RatsABSTRACT
The molybdate-stabilized glucocorticoid receptor in cytosol preparations from rat, pig and human thymus, rat liver and CEM-C7 human leukaemic lymphoblasts was characterized as its complex with [1,2,4-3H]triamcinolone acetonide, by gel filtration on Sephacryl S-300 and by ultracentrifugation on sucrose density gradients. At low ionic strength, the complex from all sources was detected as a species with a sedimentation coefficient of 9.1-9.6S and a Stokes radius of 5.70-5.80 nm (form I); this form is believed to represent the non-transformed, undegraded complex. Exposure to 0.4 M KCl in the presence of molybdate resulted, in all cases, in the generation of a smaller form (form II) with a sedimentation coefficient of 4.5-4.8S and a Stokes radius of 4.70-4.77 nm. Form II has been shown to possess properties characteristic of the transformed (activated) state. It is concluded that the glucocorticoid receptor shows pronounced interspecies and intertissue similarities, and that pig thymus may represent a convenient source of tissue for glucocorticoid receptor purification.
Subject(s)
Molybdenum , Receptors, Glucocorticoid/isolation & purification , Receptors, Steroid/isolation & purification , Animals , Cell Line , Chemical Phenomena , Chemistry, Physical , Child , Chromatography, Gel , Humans , Leukemia, Lymphoid/metabolism , Liver/metabolism , Male , Rats , Species Specificity , Swine , Thymus Gland/metabolismABSTRACT
Dissociation kinetics were determined at 0 degrees C for molybdate-stabilized glucocorticoid-receptor complexes in rat thymus cytosol. Exposure of complexes to dextran-coated charcoal had no effect on their chromatographic properties or transformation status, but dissociation rates measured after charcoal treatment were significantly lower than those determined by displacement with excess competing steroid. The dissociation rate of the [2,4,6,7-3H]prednisolone-receptor complex was similarly modified by chromatography on Lipidex 1000, but not by chromatography on Sephadex G-25 or G-75. It is concluded that treatment of glucocorticoid-receptor complexes with dextran-charcoal or Lipidex 1000 brings about a change in dissociation rate as a consequence of the removal of a lipid component from the complex.
Subject(s)
Charcoal/pharmacology , Dexamethasone/pharmacology , Dextrans/pharmacology , Glucocorticoids/metabolism , Prednisolone/metabolism , Receptors, Glucocorticoid/metabolism , Receptors, Steroid/metabolism , Thymus Gland/metabolism , Animals , Cytosol/metabolism , Kinetics , Male , Rats , Rats, Inbred Strains , Receptors, Glucocorticoid/drug effectsABSTRACT
The binding studies in this paper indicate that the catalytic unit(s) of microsomal UDP glucuronosyltransferase(s) is not accessible to N-ethylmaleimide or UDP-N-acetylglucosamine, when the enzyme is in its membrane environment. Thus a separate regulatory factor may exist within the endoplasmic reticulum membrane that mediates the stimulation of UDPglucuronosyltransferase(s) by UDP-N-acetylglucosamine. The possible role and the mode of interaction of the putative regulatory factor with the multiple forms of UDPglucuronosyltransferase are discussed.
Subject(s)
Glucuronosyltransferase/metabolism , Microsomes, Liver/enzymology , Uridine Diphosphate N-Acetylglucosamine/pharmacology , Uridine Diphosphate Sugars/pharmacology , Animals , Electrophoresis, Disc , Endoplasmic Reticulum/enzymology , Ethylmaleimide/pharmacology , Intracellular Membranes/enzymology , RatsABSTRACT
The untransformed glucocorticoid receptor of rat thymus cytosol was characterized in the form of its complex with [1,2,4-3H]triamcinolone acetonide by ion-exchange chromatography and by gel filtration and sucrose-density-gradient ultracentrifugation at different ionic strengths. Molybdate (10 mM) was present throughout all experimental procedures and prevented receptor inactivation and degradation as well as transformation. At low ionic strength the molybdate-stabilized steroid-receptor complex was detected as a single highly asymmetric entity with a Stokes radius of 5.85 nm, a sedimentation coefficient of 9.6 S and an apparent molecular weight of 236 000. This form was converted into a smaller, even more asymmetric, form in increasing proportion as the ionic strength was increased. In the presence of 0.4 M-KCl, the smaller form had a Stokes radius of 4.95 nm, a sedimentation coefficient of 4.6 S and an apparent molecular weight of 95 500. It is concluded that the glucocorticoid-receptor complex exists at low ionic strengths as a homodimer or as a heterodimer in which only one subunit possesses a steroid-binding site, and that the process of dissociation into subunits brought about by increasing the ionic strength is a process distinct from, but possibly preceding, the transformation phenomenon responsible for conferring DNA-binding properties on the complex.
Subject(s)
Molybdenum/pharmacology , Receptors, Glucocorticoid/metabolism , Receptors, Steroid/metabolism , Thymus Gland/metabolism , Animals , Centrifugation, Density Gradient , Chromatography, Gel , In Vitro Techniques , Macromolecular Substances , Male , Osmolar Concentration , Potassium Chloride/pharmacology , Rats , Rats, Inbred Strains , Receptors, Glucocorticoid/drug effects , Triamcinolone Acetonide/metabolismABSTRACT
1. Antiserum was raised against purified Wistar-rat liver UDP-glucuronyltransferase. 2. UDP-glucuronyltransferase activities towards 4-nitrophenol, bilirubin, 1-naphthol and morphine were co-immunoprecipitated from solubilized Wistar-rat liver preparations. 3. UDP-glucuronyltransferase activities towards 1-naphthol, 2-aminophenol and 4-nitrophenol were precipitated from solubilized Gunn-rat liver preparations by this antiserum. 4. UDP-glucuronyltransferase activities towards 1-naphthol, 4-nitrophenol and bilirubin, from Wistar-rat liver, were slightly inhibited by antiserum, whereas 1-naphthol UDP-glucuronyltransferase activity from Gunn-rat livers was greatly inhibited. 5. Measurable Wistar-rat liver glucuronyltransferase activities in washed immunoprecipitates indicate that the enzyme(s) were not merely inhibited by antiserum. 6. Immunoglobulin G purified from this antiserum immunoprecipitated transferase activities towards 4-nitrophenol, bilirubin and 1-naphthol. 7. The washed immunoprecipitates from both rat strains, containing UDP-glucuronyltransferase activity, appear to be similar when analysed by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. 8. Radial-immunodiffusion studies suggest that a smaller amount of UDP-glucuronyltransferase protein is present in Gunn-rat liver than in Wistar-rat liver. 9. The significance of these results in relation to the genetic deficiency in the Gunn rat is discussed.
Subject(s)
Glucuronosyltransferase/immunology , Hyperbilirubinemia, Hereditary/enzymology , Liver/enzymology , Animals , Disease Models, Animal , Electrophoresis, Polyacrylamide Gel , Glucuronosyltransferase/antagonists & inhibitors , Glucuronosyltransferase/metabolism , Immunodiffusion , Immunoglobulin G/immunology , Microsomes, Liver/enzymology , Precipitins/analysis , RatsABSTRACT
1. Reconstitution of UDP-glucuronyltransferase preparations with phosphataidylcholine liposomes facilitated the purification of testosterone UDP-glucuronyltransferase. 2. Transferase activity towards testosterone co-purifies with that towards 4-nitrophenol. 3. UDP-glucuronyltransferase activity towards oestrone was separated from that towards testosterone. 4. These results suggest that testosterone and 4-nitrophenol may be glucuronidated by a different form of UDP-glucuronyltransferase from the one glucuronidating oestrone.